Laboratorios Farmaceuticos Rovi, S.A. (LON: 0ILL)
London
· Delayed Price · Currency is GBP · Price in EUR61.65
+0.25 (0.41%)
Dec 23, 2024, 5:51 PM BST
Laboratorios Farmaceuticos Rovi Market Cap
Laboratorios Farmaceuticos Rovi has a market cap or net worth of 2.62 billion as of December 23, 2024. Its market cap has increased by 0.89% in one year.
Market Cap
2.62B
Enterprise Value
2.72B
Revenue
665.09M
Ranking
n/a
PE Ratio
19.11
Stock Price
61.65
Market Cap Chart
Since December 18, 2007, Laboratorios Farmaceuticos Rovi's market cap has increased from 104.97M to 2.62B, an increase of 2,399.76%. That is a compound annual growth rate of 20.82%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 159.00B |
| GSK plc | 53.86B |
| Haleon plc | 34.50B |
| Smith & Nephew plc | 8.48B |
| ConvaTec Group PLC | 4.52B |
| Hikma Pharmaceuticals PLC | 4.33B |
| Oxford Nanopore Technologies plc | 1.37B |
| Animalcare Group plc | 143.09M |